A method for inducing programmed cell death in cancer cells and a pharmaceutical composition therefor are provided.
Provided is a method for inducing programmed cell death in cancer cells, the method including enhancing production of nitric oxide in cancer cells. Provided is a pharmaceutical composition for inducing programmed cell death in cancer cells, the pharmaceutical composition containing, as an active component, a compound that enhances production of nitric oxide in cancer cells. Provided is use of a compound that enhances production of nitric oxide in cancer cells, in a method for preventing, improving, suppressing progression of, and/or treating cancers.
本研究提供了一种诱导癌细胞程序性死亡的方法及其药物组合物。
提供了一种诱导癌细胞程序性
细胞死亡的方法,该方法包括增强癌细胞中
一氧化氮的产生。提供了一种用于诱导癌细胞程序性
细胞死亡的药物组合物,该药物组合物作为一种活性成分,含有一种能增强癌细胞产生
一氧化氮的化合物。提供了一种在预防、改善、抑制癌症进展和/或治疗癌症的方法中使用增强癌细胞
一氧化氮生成的化合物的方法。